SECTION D E BASES

Brand Owner (click to sort) Address Description
NEOTECH GLANBIA NUTRITIONALS LIMITED Glanbia House Kilkenny R95E866 Ireland (Section 44(d) and 44(e) Bases) Flavorings for beverages; Flavourings for foods; Flavourings available in liquid, powder or emulsion forms used for various applications in food and beverages industries; Food additives for non-nutritional purposes for use as a flavoring; (Use Basis) Colours available in liquid, powder or emulsion forms used for various applications in food and beverages industries;NEO TECH;
NEOTECH FOODAROM GROUP INC. 5400 Armand-Frappier Saint-Hubert, Quebec J3Z1G5 Canada (Section 44(d) and 44(e) Bases) Flavorings for beverages; Flavourings for foods; Flavourings available in liquid, powder or emulsion forms used for various applications in food and beverages industries; Food additives for non-nutritional purposes for use as a flavoring; (Use Basis) Colours available in liquid, powder or emulsion forms used for various applications in food and beverages industries;NEO TECH;
NEOTECH METAROM NEOTECH INC. 5000 Armand-Frappier Saint-Hubert, Quebec J3Z1G5 Canada (Section 44(d) and 44(e) Bases) Flavorings for beverages; Flavourings for foods; Flavourings available in liquid, powder or emulsion forms used for various applications in food and beverages industries; Food additives for non-nutritional purposes for use as a flavoring; (Use Basis) Colours available in liquid, powder or emulsion forms used for various applications in food and beverages industries;NEO TECH;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides novel synthetic oligonucleotide sequences (hereinafter sequence) of 3 to 9 bases in length comprising one or more non-DNA bases wherein the bases are nebularine, hypoxanthine, or uracil, or combinations of nebularine, hypoxanthine and uracil bases. These sequences optionally further comprise one or more guanine bases or one or more thymine bases, or combinations thereof. The present invention also provides methods of using these compositions to induce responses in cells, and to treat diseases and conditions characterized by undesired cellular proliferation such as autoimmune disease, lymphoproliferative disease, inflammation or cancer.